, decreased disynaptic la reciprocal inhibition (2) (3) (4) , decreased disynaptic Ib autogenic inhibition (5) , and decreased (6, 7) or increased (8) clinically identical spasticity syndromes (9) . These difficulties with interpretation of experimental data underscore the importance of designing studies utilizing methods that are relatively specific for spinal inhibitory circuits and allow analysis of relevant patient subgroups.
Spinal recurrent inhibition, as mediated by the Renshaw cell (RC) ( 10) (Figure 1 ), may contribute to the selection of the most active motoneurons through inhibition of neighboring (less active) motoneurons (11) . However, models of RC function must further include complexities attributable to known inhibitory output to y-motoneurons, la inhibitory intemeurons, and other RCs (12 ( 14) . Katz Figure 2B ). Only those same fibers are free to conduct the reflex activity evoked by Sm-the H' response ( Figure   2C ). Since the same fibers conduct both reflexes, H1 and H' should theoretically be equal in amplitude. Differences between HI and H', as a function of stimulus intensity, are largely due to recurrent inhibition ( 19, 20) . Once determined by clinico-pathological correlations in defined subgroups of patients, pathogenetic mechanisms of spasticity might he used as bases for rational therapeutic approaches. In the case of the RC, sites for pharmacological manipulation include both presynaptic and postsynaptic transmitters, acetylcholine (23) and glycine (24) . Recent investigations using an !1l nitro isolated rat spinal cord preparation (25) has supported evidence from decerebrate cat experiments (25) 
